• Nenhum resultado encontrado

[PDF] Top 20 Biological dose-escalated definitive radiation therapy in head and neck cancer

Has 10000 "Biological dose-escalated definitive radiation therapy in head and neck cancer" found on our website. Below are the top 20 most common "Biological dose-escalated definitive radiation therapy in head and neck cancer".

Biological dose-escalated definitive radiation therapy in head and neck cancer

Biological dose-escalated definitive radiation therapy in head and neck cancer

... effect. In this study, for HN tumours, an a/b of 10, a potential doubling time of 3 days and a kick-off time for repopulation of 28 days were ...disregarded and an a/b of 3 was ...cetuximab. ... See full document

11

Carotid Sinus Syndrome in a Patient with Head and Neck Cancer: A Case Report

Carotid Sinus Syndrome in a Patient with Head and Neck Cancer: A Case Report

... presents in older patients, with a mean age of 75 years, and has a strong male dominance ...these, head and neck tumours are rare (<1/250) and most cases occur in the ... See full document

8

Case-control study of oral disease indexes in individuals with head and neck cancer after antineoplastic therapy

Case-control study of oral disease indexes in individuals with head and neck cancer after antineoplastic therapy

... AT, and 50% of individuals were evaluated at a time shorter than 12 months after AT, which could have interfered in the results of the DMFT ...performed in China reported that the post-AT HNC ... See full document

6

Head and Neck Cancer Treatment with Particle Beam Therapy

Head and Neck Cancer Treatment with Particle Beam Therapy

... express and describe beam ...LET radiation creates various and multi-dimensional damages and harms in DNA and other cellular structures, yielding tumor killing with fewer side ... See full document

6

Existence of benefit finding and posttraumatic growth in people treated for head and neck cancer: a systematic review

Existence of benefit finding and posttraumatic growth in people treated for head and neck cancer: a systematic review

... place in chronically ill patients, including individuals suffering from cancer (Affleck & Tennen, 1996; Carver & Antoni, 2004; Petrie et ...breast cancer (Carver & Antoni, 2004; Petrie et ... See full document

23

PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neck.

PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neck.

... importance in light of the new evidence, demonstrating that even a small decrease of PTEN activity can change the biology of the tumor and that complete loss of functionality may lead to the opposite ... See full document

8

Cytotoxic effect of Erythroxylum suberosum combined with radiotherapy in head and neck cancer cell lines

Cytotoxic effect of Erythroxylum suberosum combined with radiotherapy in head and neck cancer cell lines

... the radiation in cells is dose-dependent, and has the capacity of inducing sublethal damage sufficient to cause apoptosis ...chemotherapy and radiotherapy has better anti-cancer ... See full document

6

Genetic alterations in head and neck squamous cell carcinomas

Genetic alterations in head and neck squamous cell carcinomas

... 17p13.1 and consists of 11 exons coding for a nuclear phosphoprotein which can bind to specific DNA sequences acting as a transcription factor ...ing in protein stabilization and accumulation ... See full document

8

Impact of HPV infection on the development of head and neck cancer

Impact of HPV infection on the development of head and neck cancer

... include cancer of the hypophar- ynx, nasopharynx, oropharynx, and ...for head and neck cancer in France in 2007, and tumors were more frequently detected ... See full document

10

Different levels in alcohol and tobacco consumption in head and neck cancer patients from 1957 to 2013.

Different levels in alcohol and tobacco consumption in head and neck cancer patients from 1957 to 2013.

... name, cancer site, study design, variables adjusted or matched, risk estimates and 95% ...articles, and resolved doubts or disagreements. When same studies were published in more than one ... See full document

13

EVALUATION OF HEMATOLOGICAL PARAMETERS AS A POSSIBLE MARKER FOR HEAD-AND-NECK  CANCER AND PRECANCEROUS CONDITIONS

EVALUATION OF HEMATOLOGICAL PARAMETERS AS A POSSIBLE MARKER FOR HEAD-AND-NECK CANCER AND PRECANCEROUS CONDITIONS

... markers in blood would predict the development of cancer in its earliest stage or in precancerous ...indices and role of WBC count in the diagnosis of malignancies of the ... See full document

6

Hemochromatosis enhances tumor progression via upregulation of intracellular iron in head and neck cancer.

Hemochromatosis enhances tumor progression via upregulation of intracellular iron in head and neck cancer.

... [21], and TFR1 [21–23] in HNSCC patient samples, demonstrating that this is indeed a commonly dysregulated pathway in this ...overexpressed in other cancers including brain [24], and ... See full document

14

Rhabdomyoma of the head and neck.

Rhabdomyoma of the head and neck.

... tumor and account for 1 to 2 % of skeletal muscle ...reported. Head and neck rhabdomyomas have their origin in the third and fourth branchial clefts skeletal ...histopathological ... See full document

3

5-Methyltetrahydrofolate-homocysteine methyltransferase gene polymorphism (MTR) and risk of head and neck cancer

5-Methyltetrahydrofolate-homocysteine methyltransferase gene polymorphism (MTR) and risk of head and neck cancer

... allele and genotype distributions, similar to the data reported by Suzuki et ...with head and neck cancer had a higher frequency of the G polymorphic allele than men with no history of ... See full document

6

Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients

Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients

... failure in head and neck squamous cell carcinomas (HNSCC) and the remaining of tumor cells in surgical margins is associated with ...sensitivity in identifying cells that ... See full document

9

Cytogenetic damage in circulating lymphocytes and buccal mucosa cells of head-and-neck cancer patients undergoing radiotherapy

Cytogenetic damage in circulating lymphocytes and buccal mucosa cells of head-and-neck cancer patients undergoing radiotherapy

... from cancer patients undergo- ing radiotherapy showed no dose-dependent increase in MNC frequencies (either in blood or buccal mucosa) com- pared with their own concurrent pre-treatment ... See full document

8

Radiation-induced myocardial perfusion abnormalities in breast cancer patients following external beam radiation therapy

Radiation-induced myocardial perfusion abnormalities in breast cancer patients following external beam radiation therapy

... lampectomy and then were managed by postoperative three dimensional conformal radiotherapy (3D CRT) to the surgical ...breast cancer were considered as exposed cases in whom a fraction of the heart ... See full document

7

Management of Dysphagia in The Head and Neck Cancer Patient during COVIDCOVID-19 Pandemic: A Practical Strategy

Management of Dysphagia in The Head and Neck Cancer Patient during COVIDCOVID-19 Pandemic: A Practical Strategy

... Figure 2: Workflow for swallowing studies in head and neck patients during COVID-19 Pandemic. NPS, Nasopharyngeal swab; PPE, Personal protective equipment; PCR, Polymerase chain reaction; ... See full document

21

Rhabdomyoblastic Differentiation in Head and Neck Malignancies Other Than Rhabdomyosarcoma

Rhabdomyoblastic Differentiation in Head and Neck Malignancies Other Than Rhabdomyosarcoma

... experiments in the Triton salamander in which dissection and ectopic re-implantation of the sciatic nerve was associated with formation of supernumerary ‘limbs’ containing skeletal muscle and ... See full document

12

Inhibition of STAT3 by niclosamide synergizes with erlotinib against head and neck cancer.

Inhibition of STAT3 by niclosamide synergizes with erlotinib against head and neck cancer.

... embedded in paraffin and cut into 4-µm ...Laboratories) and counterstained with hematoxylin (Vector Laboratories), dehydrated, treated with xylene, and ...examined and representative ... See full document

13

Show all 10000 documents...